Bovie Medical

Bovie Medical Corporation was an American medical-device manufacturer focused on electrosurgical equipment, electrocautery products, and energy-based technologies. The company was founded in Purchase, New York, in 1978 and took its name from William T. Bovie, the American scientist and inventor associated with the development of the electrosurgical generator in 1926. The name therefore connected the company directly to the history of surgical electrosurgery rather than to a consumer medical brand or healthcare provider. Bovie Medical became a publicly traded company in 1983, initially listing on the New York Stock Exchange under the ticker BVX. Its business combined conventional electrosurgical products with newer energy technologies intended for medical and cosmetic-surgery applications. Electrosurgical products generally use controlled electrical energy to cut tissue, coagulate bleeding, or perform electrocautery-related procedures. This placed Bovie in a specialized medical-device segment serving clinical users who require powered surgical instruments and generators. The company was headquartered in Clearwater, Florida, and also maintained a manufacturing facility in Bulgaria. Its activities extended beyond traditional electrosurgery through an advanced-energy business associated with cosmetic surgery. One of the named technologies in this area was Renuvion, a platform developed for energy-based surgical and aesthetic procedures. The existence of this advanced-energy unit gave Bovie a broader identity than a manufacturer of conventional electrocautery equipment alone. A major corporate transition occurred at the beginning of 2019. On January 1, 2019, Bovie Medical rebranded as Apyx Medical and began trading under the NASDAQ ticker APYX. This change reflected the company’s emphasis on advanced-energy technologies and marked the end of Bovie Medical as the company’s primary corporate identity. The Bovie name nevertheless remained relevant as a historical label for the earlier business and for its electrosurgical heritage. In August 2019, the company sold its electrocauterization business to Symmetry Surgical Inc. The divestiture separated the conventional electrocautery portion of the former Bovie operation from the advanced-energy activities associated with the Apyx Medical identity. As a result, Bovie Medical is best understood as a predecessor corporate brand and historical medical-device company rather than an active independent brand. Its legacy rests on the combination of long-standing electrosurgical products, the Bovie name’s association with surgical energy, and the later strategic shift toward advanced energy and cosmetic-surgery applications.

Bovie Medical Corporation was established in 1978 in Purchase, New York, as a manufacturer serving the medical-device market. Its name honored William T. Bovie, an American scientist and inventor credited with inventing the electrosurgical generator in 1926. That namesake gave the company a clear historical connection to electrosurgery, a field in which electrical energy is used during surgery for cutting, coagulation, and related tissue-management functions. The company’s principal activities centered on medical devices, electrosurgical products, and energy technologies. Its portfolio included equipment associated with electrocautery and surgical energy, while its broader technology activities later included an advanced-energy unit aimed at cosmetic surgery. The Renuvion device was identified as part of this advanced-energy business. This combination allowed the company to operate across both established electrosurgical categories and newer energy-based procedures. Bovie Medical became publicly traded in 1983, when it was listed on the New York Stock Exchange under the symbol BVX. During its corporate life, the company was based in Clearwater, Florida, and operated a manufacturing facility in Bulgaria. The available historical account does not identify a founder, chief executive, or other named corporate officer, so those details are not included here. The company changed its identity at the beginning of 2019. On January 1, it rebranded as Apyx Medical and adopted the NASDAQ ticker APYX. The rebranding represented a shift away from the Bovie corporate name and toward an identity associated with advanced-energy technologies. The former Bovie business consequently became a predecessor operation within the continuing Apyx Medical corporate story rather than an active standalone company. A further separation followed in August 2019, when the electrocauterization portion of the business was sold to Symmetry Surgical Inc. This transaction distinguished the conventional electrocautery activities from the advanced-energy activities retained under the Apyx Medical identity. In historical terms, Bovie Medical therefore represents the company’s original electrosurgical and medical-device identity, while Apyx Medical represents its post-2019 corporate and strategic direction. Bovie Medical is now treated as a defunct or superseded corporate brand, with its principal legacy found in electrosurgical equipment, the Bovie name, and the transition toward advanced surgical-energy technologies.

• 2019

  Rebranded as Apyx Medical

  [1]Bovie Medicalen.wikipedia.org

  On January 1, Bovie Medical adopted the Apyx Medical name and began trading under the NASDAQ ticker APYX.

• 2019

  Electrocauterization business sold

  [1]Bovie Medicalen.wikipedia.org

  In August, the electrocauterization portion of the business was sold to Symmetry Surgical Inc.

• 1983

  Became publicly listed

  [1]Bovie Medicalen.wikipedia.org

  The company went public and was listed on the New York Stock Exchange under the ticker BVX.

• 1978

  Company founded in Purchase, New York

  [1]Bovie Medicalen.wikipedia.org

  Bovie Medical Corporation was founded in Purchase, New York, as a medical-device manufacturer.

• 1926

  William T. Bovie associated with electrosurgical generator invention

  [1]Bovie Medicalen.wikipedia.org

  The company’s namesake, William T. Bovie, was credited with inventing the electrosurgical generator, establishing the historical association behind the Bovie name.

A specialized medical-device manufacturer positioned around electrosurgical equipment and energy-based surgical technologies, later emphasizing advanced energy for cosmetic and aesthetic procedures.

• Medical devices

  Electrosurgical products

  Bovie Medical’s core product area consisted of electrosurgical devices and related equipment. These products served procedures in which controlled electrical energy is used for tissue cutting, coagulation, or electrocautery. The category formed the historical foundation of the company and reflected the connection between the Bovie name and the development of surgical electrosurgery.

• Advanced surgical energy

  Renuvion

  Renuvion was identified as an advanced-energy device associated with the company’s cosmetic-surgery business. It represented Bovie Medical’s expansion beyond conventional electrocautery into energy-based technologies for aesthetic and cosmetic procedures. Following the 2019 corporate rebranding, the advanced-energy focus became associated with Apyx Medical rather than the Bovie Medical name.

• 2019

  Corporate rebranding to Apyx MedicalStrategy

  Background

  Bovie Medical had developed an advanced-energy business alongside its established electrosurgical operations. The company changed its corporate identity as it emphasized the advanced-energy direction.

  Action taken

  Effective January 1, 2019, the company rebranded as Apyx Medical and changed its market listing from the former BVX identity to the NASDAQ ticker APYX.

  Aftermath

  Bovie Medical became a historical predecessor name, while Apyx Medical became the continuing corporate identity.

  Source

• 2019

  Divestiture of electrocauterization operationsM&A

  Background

  After the company adopted the Apyx Medical identity, it separated the conventional electrocauterization portion of the former Bovie business from its advanced-energy activities.

  Action taken

  In August 2019, the electrocauterization business was sold to Symmetry Surgical Inc.

  Aftermath

  The transaction left the Bovie electrocautery operation under a different ownership arrangement and reinforced the successor company’s emphasis on advanced-energy technologies.

  Source

• 2019

  Bovie Medical rebrands as Apyx Medical and adopts APYX ticker[1]Bovie Medicalen.wikipedia.org

  Leadership change · Other

  Effective January 1, 2019, Bovie Medical changed its corporate name to Apyx Medical and began trading on NASDAQ under the APYX symbol.

• 2019

  Bovie Medical sells electrocauterization business to Symmetry Surgical[1]Bovie Medicalen.wikipedia.org

  M&A

  In August 2019, the electrocauterization portion of the former Bovie Medical business was sold to Symmetry Surgical Inc.

1. 1Bovie Medicalen.wikipedia.org